Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension and Weight Loss

Irina Shishkina, Danielle Bradshaw, Gita Giddens, Courtney Corley, Kimberly Green, Rachel Ashley, Sarah Jimenez, Locke Johnson Bryan, Ayushi Chauhan, Amany R. Keruakous, Molly Denlinger, Mohammad Mian, Ravindra Kolhe, Vamsi K. Kota, Anand Jillella

Blood (2023) 142 (Supplement 1): 6660.

https://doi.org/10.1182/blood-2023-190909

Published: 2023

Journal Articles

Incremental Clinically Relevant Information in 70 CLL Cases with Optical Genome Mapping: Going Beyond Karyotype and FISH

Nikhil Sahajpal, Anand P. Jillella, Ashis Mondal, Harmanpreet Singh, Ashutosh Vashisht, Huidong Shi, Vamsi K. Kota, Ravindra Kolhe

Blood (2022) 140 (Supplement 1): 12361–12362.

https://doi.org/10.1182/blood-2022-168454

Published: 2022

Journal Articles

Musculoskeletal Pain Syndrome in a Subset of APL Patients during Induction Therapy

Michal Jakub Kubiak, Anand P. Jillella, Danielle Bradshaw, Natasha M. Savage, Ravindra Kolhe, Locke J. Bryan, Vamsi K. Kota

Blood (2022) 140 (Supplement 1): 8948–8949.

https://doi.org/10.1182/blood-2022-168090

Published: 2022

Journal Articles

Time to Abandon the Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy

Zachery Clint Branham, Chijioke Okereke, Mahran Shoukier, Danielle Bradshaw, Ravindra Kolhe, Anand P. Jillella, Vamsi K. Kota

Blood (2022) 140 (Supplement 1): 8929.

https://doi.org/10.1182/blood-2022-164963

Published: 2022

Journal Articles

Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss

Anand P. Jillella, Irina Shishkina, Gita Giddens, Courtney Corley, Kimberly Green, Rachel Ashley, Megan Johnson, Laura Walker, Sarah Jimenez, Locke J. Bryan, Ayushi Chauhan, Amany R. Keruakous, Molly James, Mohammad A.H. Mian, Danielle Bradshaw, Ravindra Kolhe, Vamsi K. Kota

Blood (2022) 140 (Supplement 1): 12547–12548.

https://doi.org/10.1182/blood-2022-166437

Published: 2022

Journal Articles

Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study

Marisol Miranda, Ravindra Kolhe, Danielle Bradshaw, Jaspreet Farmaha, Kimya Jones, Harmanpreet Singh, Ashutosh Vashisht, Nikhil Sahajpal, Jorge E. Cortes

Blood (2022) 140 (Supplement 1): 12210.

https://doi.org/10.1182/blood-2022-170363

Published: 2022

Journal Articles

Unraveling Gene Fusions with Optical Genome Mapping in Hematological Malignancies: The Unexplored Terrain

Nikhil Sahajpal, Vamsi K. Kota, Anand P. Jillella, Ashis Mondal, Ravindra Kolhe

Blood (2022) 140 (Supplement 1): 11478–11479.

https://doi.org/10.1182/blood-2022-170625

Published: 2022

Journal Articles

Homologous Recombination Deficiency (HRD) in Hematological Malignancies

Nikhil Sahajpal, Vamsi K. Kota, Anand P. Jillella, Ashis Mondal, Ravindra Kolhe

Blood (2022) 140 (Supplement 1): 11839–11840.

https://doi.org/10.1182/blood-2022-170583

Published: 2022

Journal Articles

Optical Genome Mapping and Comprehensive Next Generation Sequencing Panel for Myeloid Cancers: New Era of Complimentary Profiling

Nikhil Sahajpal, Ashis Mondal, Anand P. Jillella, Vamsi Kota, Ravindra Kolhe

Blood (2022) 140 (Supplement 1): 9175–9176.

https://doi.org/10.1182/blood-2022-170638

Published: 2022

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation Improves Survival in Patients with Multiple Myeloma and End Stage Renal Disease

Sandeep Anand Padala, Anusha Vakiti, Wendy Bollag, Jennifer Waller, Mufaddal Kheda, Stephanie L Baer, Ravindra Kolhe, Mohammad A.H. Mian, Anand P. Jillella, Jorge E. Cortes, Vamsi Kota

Blood (2022) 140 (Supplement 1): 7697–7698.

https://doi.org/10.1182/blood-2022-170672

Published: 2022

Journal Articles

Impact of Qualified Dedicated APL Leukemia Specialist and Simplified Treatment Algorithm on Early Deaths in APL, a Monocenter Experience

Michal Jakub Kubiak, Anand P. Jillella, Danielle Bradshaw, Natasha M. Savage, Locke J. Bryan, Ravindra Kolhe, Vamsi K. Kota

Blood (2022) 140 (Supplement 1): 6108–6109.

https://doi.org/10.1182/blood-2022-168155

Published: 2022

Journal Articles

Central Line Associated Bloodstream Infection Rate Among Hematologic Malignant Patients Who Received Antimicrobial Prophylaxis in the Inpatient Setting

Sujith Abbagoni, Thuy Le, Locke J. Bryan, Mohammad A. H. Mian, Danielle Bradshaw, Ashley D Fox, Anand P Jillella, Chijioke Okereke, Ravindra Kolhe, Natasha M. Savage, Vamsi Kota

Blood (2021) 138 (Supplement 1): 4390.

https://doi.org/10.1182/blood-2021-154524

Published: 2021

Journal Articles

Rates of Neutropenic Fever in Patients with Hematologic Malignant Diseases with Central Venous Access

Sujith Abbagoni, Sarah Malik, Ashley D Fox, Mohammad A. H. Mian, Tahsin Anwar, Danielle Bradshaw, Locke J. Bryan, Anand P Jillella, Ravindra Kolhe, Natasha M. Savage, Sandeep Padala, Vamsi Kota

Blood (2021) 138 (Supplement 1): 4953.

https://doi.org/10.1182/blood-2021-154465

Published: 2021

Journal Articles

Serum Albumin As a Prognostic Factor for Overall Survival at 6-Months in Acute Myeloid Leukemia (AML)

Ashley D Fox, Chijioke Okereke, Thuy Le, Anand P Jillella, Locke J. Bryan, Tahsin Anwar, Mohammad A. H. Mian, Danielle Bradshaw, Ravindra Kolhe, Natasha M. Savage, Germame Ajebo, Sandeep Padala, Sujith Abbagoni, Vamsi Kota

Blood (2021) 138 (Supplement 1): 1226.

https://doi.org/10.1182/blood-2021-154138

Published: 2021

Journal Articles

Racial Variations in Mutational Profile in Newly Diagnosed Acute Myeloid Leukemia Patients

Tahsin Anwar, Mohammed Mian, Mahran Shoukier, Achuta K Guddati, Moinul Hossain, Ravindra Kolhe, MD PhD, Locke J. Bryan, Anand P Jillella, MD, Jorge E. Cortes, MD, Vamsi Kota, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-143329

Published: 2020

Journal Articles

Outcomes of FLT3-Mutated Acute Myeloid Leukemia Patients: A Single Center Real-World Experience

Mahran Shoukier, Vamsi Kota, MD, Ravindra Kolhe, MD PhD, Locke J. Bryan, Anand P Jillella, MD, Jorge E. Cortes, MD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-135940

Published: 2020

Journal Articles

Indoximod Combined with Standard Induction Chemotherapy Is Well Tolerated and Induces a High Rate of Complete Remission with MRD-Negativity in Patients with Newly Diagnosed AML: Results from a Phase 1 Trial

Ashkan Emadi, MD PhD, Vu H. Duong, MD, Jeremy Pantin, MD, Mohammad Imran, MD, Rima Koka, MD PhD, Zeba Singh, MBBS, Edward A. Sausville, MD PhD, Jennie Y. Law, MD, Seung Tae Lee, MD PhD, Huidong Shi, PhD, Ravindra Kolhe, MD PhD, Maria R. Baer, MD, Michael R. Loken, PhD, Eugene P. Kennedy, MD, Charles Link, MD, David H. Munn, MD

Blood (2018) 132 (Supplement 1): 332.

https://doi.org/10.1182/blood-2018-99-117433

Published: 2018

Journal Articles

Molecular Characterization By Cancer Immune Profiling in Acute Promyelocytic Leukemia (APL) May Identify Patients at Risk of Early Death

Ravindra Kolhe, MD PhD, Chetan Pundkar, DVM, Ashis Mondal, PhD, Jeremy Pantin, MBBS, Vamsi Kota, MBBS, Amber Clemmons, Anand Jillella, MD

Blood (2017) 130 (Supplement 1): 4976.

https://doi.org/10.1182/blood.V130.Suppl_1.4976.4976

Published: 2017

Journal Articles

A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia

Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Stephanie Debragga, Sheldon Bolds, Saleh Alghsoon, Martha L. Arellano, MD, Ravindra Kolhe, MD PhD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 4869.

https://doi.org/10.1182/blood.V130.Suppl_1.4869.4869

Published: 2017

Journal Articles

Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism

Jianguang Chen, Warren Fiskus, Kelly Eaton, Pravina Fernandez, Yongchao Wang, Rekha Rao, Pearl Lee, Rajeshree Joshi, Yonghua Yang, Ravindra Kolhe, Ramesh Balusu, Prasanthi Chappa, Kavita Natarajan, Anand Jillella, Peter Atadja, Kapil N. Bhalla

Blood (2009) 113 (17): 4038–4048.

https://doi.org/10.1182/blood-2008-08-176024

Published: 2009

Includes: Supplemental data

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension and Weight Loss

Incremental Clinically Relevant Information in 70 CLL Cases with Optical Genome Mapping: Going Beyond Karyotype and FISH

Musculoskeletal Pain Syndrome in a Subset of APL Patients during Induction Therapy

Time to Abandon the Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy

Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss

Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study

Unraveling Gene Fusions with Optical Genome Mapping in Hematological Malignancies: The Unexplored Terrain

Homologous Recombination Deficiency (HRD) in Hematological Malignancies

Optical Genome Mapping and Comprehensive Next Generation Sequencing Panel for Myeloid Cancers: New Era of Complimentary Profiling

Autologous Hematopoietic Stem Cell Transplantation Improves Survival in Patients with Multiple Myeloma and End Stage Renal Disease

Impact of Qualified Dedicated APL Leukemia Specialist and Simplified Treatment Algorithm on Early Deaths in APL, a Monocenter Experience

Central Line Associated Bloodstream Infection Rate Among Hematologic Malignant Patients Who Received Antimicrobial Prophylaxis in the Inpatient Setting

Rates of Neutropenic Fever in Patients with Hematologic Malignant Diseases with Central Venous Access

Serum Albumin As a Prognostic Factor for Overall Survival at 6-Months in Acute Myeloid Leukemia (AML)

Racial Variations in Mutational Profile in Newly Diagnosed Acute Myeloid Leukemia Patients

Outcomes of FLT3-Mutated Acute Myeloid Leukemia Patients: A Single Center Real-World Experience

Indoximod Combined with Standard Induction Chemotherapy Is Well Tolerated and Induces a High Rate of Complete Remission with MRD-Negativity in Patients with Newly Diagnosed AML: Results from a Phase 1 Trial

Molecular Characterization By Cancer Immune Profiling in Acute Promyelocytic Leukemia (APL) May Identify Patients at Risk of Early Death

A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia

Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only